Epstein-Barr virus infection at mucosal surfaces: detection of genomic variants with altered pathogenic potential
- PMID: 1664984
- DOI: 10.1007/BF00201467
Epstein-Barr virus infection at mucosal surfaces: detection of genomic variants with altered pathogenic potential
Similar articles
-
Molecular basis for Epstein-Barr virus induced pathogenesis and disease.Springer Semin Immunopathol. 1991;13(2):133-46. doi: 10.1007/BF00201464. Springer Semin Immunopathol. 1991. PMID: 1664982 Review. No abstract available.
-
Chronic active Epstein-Barr virus (EBV) infection is associated with clonotypic intracellular terminal regions of the EBV.J Infect Dis. 1989 Sep;160(3):546-7. doi: 10.1093/infdis/160.3.546a. J Infect Dis. 1989. PMID: 2547884 No abstract available.
-
Themed issue: the biology and pathology of the Epstein-Barr virus.Mol Pathol. 2000 Oct;53(5):219-21. doi: 10.1136/mp.53.5.219. Mol Pathol. 2000. PMID: 11091845 Free PMC article. No abstract available.
-
Variations among isolates of Epstein-Barr virus.Ann N Y Acad Sci. 1980;354:309-25. doi: 10.1111/j.1749-6632.1980.tb27974.x. Ann N Y Acad Sci. 1980. PMID: 6261649 Review. No abstract available.
-
Increased levels of Epstein-Barr virus DNA in lacrimal glands of Sjögren's syndrome patients.Acta Ophthalmol Scand. 1995 Oct;73(5):425-30. doi: 10.1111/j.1600-0420.1995.tb00302.x. Acta Ophthalmol Scand. 1995. PMID: 8751122
Cited by
-
Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins.J Virol. 2002 Mar;76(5):2469-79. doi: 10.1128/jvi.76.5.2469-2479.2002. J Virol. 2002. PMID: 11836425 Free PMC article.